KC
UROV

Kellner Capital’s Urovant Sciences Ltd. UROV Stock Holding History

Kellner Capital’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-90,000
Closed -$1.45M – 34
2020
Q4 		$1.45M Buy
+90,000
New +$1.12M 0.77% 23

Kellner Capital's UROV Position: Q1 2021 in Review

Kellner Capital sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 90,000 shares — an estimated $1.45M sold.

Kellner Capital first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $1.45M in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

  • Kellner Capital reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
  • Kellner Capital sold 90,000 Urovant Sciences Ltd. shares in Q1 2021, an estimated $1.45M.
  • Kellner Capital first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
  • Kellner Capital's Urovant Sciences Ltd. position peaked at $1.45M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Kellner Capital's 13F filing for Q1 2021, filed 10 May 2021.